Related Experiment Videos

[Quantitative changes of bacterial flora from the oral cavity and throat in children with acute lymphoblastic

Z Krzemiński1, E Majda-Stanisławska

  • 1Zakład Mikrobiologii Lekarskiej AM w Lodzi

Medycyna Doswiadczalna I Mikrobiologia
|January 1, 1993
PubMed

Insights

Children with acute lymphoblastic leukemia (ALL) undergoing intensive treatment show significantly higher levels of oral and throat bacteria, including Gram-negative rods, compared to healthy children. This indicates a compromised oral microbiome in pediatric leukemia patients on cytostatics.

Area of Science:

  • Microbiology
  • Pediatric Oncology
  • Immunology

Context:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Intensive chemotherapy (cytostatics) can impact the immune system and oral microbiome.
  • The oral cavity and throat harbor a complex bacterial ecosystem.

Purpose:

  • To quantitatively investigate the aerobic and anaerobic bacterial flora in the oral cavity and throat of children with ALL.
  • To compare the oral and throat bacterial profiles of leukemic children undergoing cytostatic treatment with those of healthy children.
  • To identify specific bacterial changes associated with pediatric leukemia and its treatment.

Summary:

  • Saliva samples from 44 children (5-10 years) with ALL treated with cytostatics showed significantly higher aerobic bacteria, especially streptococci and enterococci, compared to 23 healthy controls.
  • Throat samples revealed differences primarily in staphylococci presence.
  • Notably, Gram-negative rods were detected in leukemic children but absent in the control group, indicating significant dysbiosis.

Impact:

  • Findings highlight a significantly altered oral and throat microbiome in pediatric ALL patients undergoing intensive treatment.
  • The increased presence of potentially pathogenic bacteria like Gram-negative rods may increase infection risk in immunocompromised children.
  • This research underscores the importance of monitoring and potentially managing the oral microbiome in pediatric cancer patients.

Related Concept Videos